Gendia | Home Page

GENDIA (for GENetic DIAgnostic Network) is an international network consisting of more than 100 laboratories located in the USA, Europe, Asia and Australia. GENDIA currently offers more than 2000 different genetic tests, including molecular tests for more than 1200 genes. The mission of GENDIA is to improve the accessibility, cost-effectiveness and quality of genetic diagnostics on a global scale.

Latest Gendia News: December 16, 2011: GENDIA now offers 3 new NGS (next-generation sequencing) platforms: 1. A NGS platform for sequencing of 15 cancer genes, including the breast cancer genes: BRCA1, BRCA2, CHEK2, PALB2, BRIP1, BARD1, CDH1, ATM, TP53, PTEN, STK11, RAD50, RAD51C, MRE11A and NBN. The panel costs 2900 Euro. 2. A NGS platform for sequencing of 10 genes implicated in aortic aneurysm, including: ACTA2, CBS, FBN1, FBN2, MYH11, COL3A1, SLC2A10, SMAD3, TGFBR1 and TGFBR2. The panel costs 2900 Euro. 3. A NGS platform for sequencing of 12 genes implicated in Primary Ciliary Dyskinesia, including: DNAAF1/LRRC50, DNAAF2/c14orf104, DNAH5, DNAH11, DNAI1, DNAI2, RSPH4A, RSPH9, TXNDC3, OFD1, RPGR and CFTR. The panel costs 3400 Euro. Once a variant is identified, family members can be screened for that mutation at 250 Euro. The turnaround time of the tests is 3 months. More...